Is polycystic ovarian syndrome being over-diagnosed? Today we are joined by Leah Hechtman to share some insight into new biomarkers with a stronger association to ovarian function that are now in early stages of research, and so far the results look promising. Both from a diagnostic perspective, but also for predicting fertility outcomes, these new biomarkers could mean less fear and uncertainty about having a family, but also, potentially less intrusive medical interventions in the long term. Leah will be presenting on the topic of "Optimising Fertility for the PCOS patient," at the forthcoming ATMS PCOS Symposium in Sydney in September 2018. For clinician's working in the areas of women's health, you do not want to miss this outstanding educational opportunity. Find today's show notes and full transcript here: https://www.fxmedicine.com.au/content/emerging-biomarkers-pcos-and-fertility-leah-hechtman *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****